Cancer Research Education Program
Cancer Research Education Program
批准号:
9789849
负责人:
Jason Yustein
金额:
$5.81万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAntineoplastic AgentsAreaAwarenessBioinformaticsBiological SciencesBiometryCollaborationsCommunicationCommunity OutreachComprehensive Cancer CenterCultural DiversityCultural SensitivityDevelopmentDisciplineDoctor of PharmacyDoctor of PhilosophyEducationEducational CurriculumEducational workshopElectronic MailEmerging TechnologiesEngineeringEnvironmentExposure toFacultyFellowshipFosteringFutureGRE PreparationGoalsGrantIndividualInfrastructureInstitutesInstitutionInternationalJointsKnowledgeMalignant NeoplasmsMedicineMentorsMethodsParticipantPharmacy facilityPhysicsPilot ProjectsPostdoctoral FellowReadinessReportingResearchResearch PersonnelSchoolsScienceSeriesSocial SciencesStudentsTrainingUnderrepresented StudentsUnderserved PopulationUniversitiesanticancer researchcancer health disparitycareercareer developmentcollegedesigndrug developmentdrug discoveryeducation researchexperiencefaculty researchgraduate studenthealth disparityinterestmembermid-career facultymultidisciplinaryoutreachoutreach programprofessorprogramsrecruitresearch and developmentresearch facilityscience educationskillssocial mediaundergraduate researchundergraduate studentuniversity studentweb site
中文摘要
好了!
项目总结(CREP)
加州大学癌症研究教育合作项目(CREP)的总体目标
休斯顿(UH)和NCI指定的位于贝勒的丹·L·邓肯综合癌症中心(DLDCCC)
医学院(BCM)是鼓励和准备未被充分代表(UR)的本科生和毕业生
学生进入癌症研究的职业生涯。我们建议提供癌症研究经验,开发
新的针对癌症的课程,并通过独立的、尚未完成的
目标相辅相成。而整个P20合作将在UH药学院(UHCOP)之间进行
和DLDCCC,合作的CREP将吸引UH的本科生和研究生
在密歇根大学和BCM进行癌症研究。首先,我们将提升中国人的癌症研究经验
本科生和研究生。这将通过以下方式实现:(1)为密歇根大学本科生提供
UH和DLDCCC在抗癌药物发现和开发领域的研究经验,(2)
以跨机构的方式提供对核心研究设施的访问,并共享论文成员资格
UH和DLDCCC加强研究生研究能力和曝光率的委员会,
(3)利用国家研究辅导网开发的myNRMN和辅导模块
(NRMN),让研究导师在研究指导中有效地解决文化多样性问题
两性关系。第二,我们将为本科生和学生开发新的癌症研究课程和方法
研究生。在这里,我们将开发一个关于癌症研究的多学科研讨会系列,以揭露UH
多个癌症研究领域的本科生和一个新的联合课程--“新兴技术”
在癌症药物发现/开发方面,这将对研究生现有的课程做出重大贡献
UH和DLDCCC/BCM的学生。第三,我们将准备不同文化差异的健康差异意识癌症
研究人员。这将通过加强UR学生获得指导和职业发展的机会来实现
活动,如新创建的“与癌症研究人员共进午餐”系列,以其他UR癌症为特色
研究人员在其职业生涯的不同阶段,为本科生和专业人员提供GRE预科课程
研究生发展助学金/研究金发展讲习班。提高对……的认识
除了癌症健康差距,我们还将在DLDCCC推出关于癌症健康差距的新系列研讨会
并通过参与大区外展为CREP参与者提供社区外展机会
该方案由DLDCCC的外展和健康差距办公室组织。总而言之,我们的协作
CREP将建立所需的关键基础设施,以支持增加
正在筹备UR癌症研究培训生,并支持提交未来机构的培训补助金
在受训人员一级提供助学金和研究金/职业发展补助金。
英文摘要
!
PROJECT SUMMARY (CREP)
The overall goal of the collaborative cancer research education program (CREP) between University of
Houston (UH) and the NCI-designated Dan L. Duncan Comprehensive Cancer Center (DLDCCC) at Baylor
College of Medicine (BCM) is to encourage and prepare underrepresented (UR) undergraduate and graduate
students to enter careers in cancer research. We propose to provide cancer research experiences, develop
new cancer-specific curricula, and create educational outreach efforts to UR students through independent, yet
complementary aims. While the overall P20 collaboration will be between UH College of Pharmacy (UHCOP)
and DLDCCC, the collaborative CREP will engage undergraduate students at UH and graduate students
conducting cancer research at UH and BCM. First, we will enhance the cancer research experience of
undergraduate and graduate students. This will be done by (1) providing UH undergraduate students with
research experience in the area of cancer drug discovery and development at both UH and DLDCCC, (2)
providing access to core research facilities in a cross-institutional manner and by shared membership of thesis
committee to augment the research capabilities and exposure of the graduate students at UH and DLDCCC,
and (3) utilizing myNRMN and mentoring modules developed by National Research Mentoring Network
(NRMN) for research mentors to effectively address cultural diversity matters in research mentoring
relationships. Second, we will develop new cancer research curricula and methods for undergraduate and
graduate students. Here, we will develop a multi-disciplinary seminar series on cancer research to expose UH
undergraduate students to multiple areas of cancer research and a new joint course on “emerging technologies
in cancer drug discovery/development” that will significantly contribute to the existing curriculum of graduate
students at both UH and DLDCCC/BCM. Third, we will prepare culturally diverse health disparity aware cancer
researchers. This will be done by enhancing access of UR students to mentoring and career development
activities such as a newly created “Lunch with Cancer Researchers” series featuring other UR cancer
researchers in various stages of their career, a GRE prep course for undergraduates, and professional
development workshop on grant/fellowship development for graduate students. To increase awareness of
cancer health disparities, we will also launch a new seminar series on cancer health disparities at DLDCCC
and provide community outreach opportunities for CREP participants through engagement in Theater Outreach
Program organized by the Office out Outreach and Health Disparity at DLDCCC. In summary, our collaborative
CREP will establish the critical infrastructure needed to support a long-term sustained effort for increasing the
pipeline of UR trainees in cancer research and also to bolster submission of future training grants at institution
level and fellowship/career development grants at the trainee level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting and targeting oncogenic functions of PAK4 in high-risk rhabdomyosarcoma
-
批准号:10577174
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2022
-
负责人:Jason Yustein
-
依托单位:
1/2: UHCOP-DLDCCC alliance: Cancer drug discovery/development and education
-
批准号:9789213
-
项目类别:
-
资助金额:$3.11万
-
财政年份:--
-
负责人:Jason Yustein
-
依托单位:
海外基金